SCHEMBL18057977

SCHEMBL18057977

CC1(C)c2ccccc2-c2ccc3c4ccc5ccccc5c4n(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15434215 0.93 L3MBTL1 (0.35) MAPTKDM4EMAPK1SMN1; SMN2L3MBTL1
SCHEMBL18057978 0.89 TNF (0.41) —
SCHEMBL18058247 0.89 TNF (0.33) —
SCHEMBL2603527 0.88 DUSP3 (0.36) MAPTKDM4EMAPK1SMN1; SMN2L3MBTL1
SCHEMBL18057914 0.87 KDM4E (0.32) MAPTKDM4EMAPK1SMN1; SMN2L3MBTL1
SCHEMBL18059338 0.86 ACVR1 (0.32) MAPTMEN1KMT2ALMNA
SCHEMBL18057974 0.86 FABP1 (0.34) MAPTKDM4ESMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL25999740 0.86 DUSP3 (0.34) L3MBTL1
SCHEMBL15625648 0.86 DUSP3 (0.34) L3MBTL1
SCHEMBL2603573 0.85 KDM4E (0.34) KDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160260909-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160260909-A1 Organic Electroluminescent Materials and Devices PNMT, CYCS, NES MAPT 198/4885KDM4E 2235/4885MAPK1 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback